Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

c-Met inhibition

Ravi Salgia1

  • 1Thoracic Oncology Research Program, Department of Medicine, Section of Hematology and Oncology, University of Chicago, USA.

Clinical Advances in Hematology & Oncology : H&O
|December 5, 2006
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current paradigm of EGFR<sup>ins20</sup> in non-small cell lung cancer: A long way forward.

Med (New York, N.Y.)·2025
Same author

Molecular PET imaging: Unlocking the secrets of cancer metabolism.

Biochemical pharmacology·2025
Same author

Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeutics.

Biochimica et biophysica acta. Reviews on cancer·2025
Same author

Targeting the oncoprotein RLIP as novel therapy for ovarian cancer.

Journal of ovarian research·2025
Same author

Conformational dynamics and multimodal interaction of Paxillin with the focal adhesion targeting domain.

Science advances·2025
Same author

Mitochondrial Dynamics Through the Lens of Nonlinear Chemical Oscillations: A Theoretical Exploration Inspired by the Belousov-Zhabotinsky Reaction.

bioRxiv : the preprint server for biology·2025
Same journal

Clinical response with cabozantinib plus nivolumab, a first-line therapy in advanced renal cell carcinoma: a clinical case report.

Clinical advances in hematology & oncology : H&O·2026
Same journal

Active treatment in high-risk, early-stage CLL or SLL.

Clinical advances in hematology & oncology : H&O·2026
Same journal

Targeting human kallikrein 2 in prostate cancer.

Clinical advances in hematology & oncology : H&O·2026
Same journal

Targeting BRAF V600E mutations in metastatic colorectal cancer.

Clinical advances in hematology & oncology : H&O·2026
Same journal

The development of second-generation KRAS inhibitors.

Clinical advances in hematology & oncology : H&O·2026
Same journal

Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.

Clinical advances in hematology & oncology : H&O·2026
See all related articles